Skip to main content
Premium Trial:

Request an Annual Quote

BioMérieux, Hitachi Partner on MDx Development, Distribution

NEW YORK (GenomeWeb News) – In vitro diagnostics developer BioMérieux has struck a strategic partnership with Hitachi High-Technologies to develop microbiology and molecular diagnostic systems, BioMérieux said today.
The companies will work together to develop new instruments to be made by Hitachi High-Technologies and distributed through BioMérieux’s worldwide commercial network. The partners did not disclose terms of the alliance.
BioMérieux CEO Stéphane Bancel said the company’s strategy through the year 2012 “is to bring full automation to microbiology laboratories around the world.”

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.